STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
STAT News · LC · trust 53/100
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
Read the original at STAT News →
Open in TruthVane →